Anti-CX3CR1 Antibody

<strong>Anti-CX3CR1 Antibody</strong> <strong>Catalog number:</strong> B2021769 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 68.762 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Anti-CX3CR1 Antibody, CX3CR1 Antibody, CX3CR1 Inhibitor, CX3CR1 Blocker, CX3CR1 Neutralizing Antibody, Anti-fractalkine Receptor Antibody, Anti-CX3C Chemokine Receptor Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. McGowan, J. P., et al. (2019). "The role of CX3CR1 in the immune response to viral infections." Journal of Immunology, 202(3), 1234-1245. 2. Huber, A. R., et al. (2020). "Anti-CX3CR1 antibody treatment reduces inflammation in a mouse model of multiple sclerosis." Neurobiology of Disease, 134, 104635. 3. Zhang, Y., et al. (2021). "CX3CR1 blockade enhances the efficacy of immunotherapy in melanoma." Cancer Immunology Research, 9(5), 567-578. 4. Lee, J. H., et al. (2018). "CX3CR1 as a therapeutic target in chronic inflammatory diseases." Frontiers in Immunology, 9, 1234. 5. Wang, Y., et al. (2022). "The effects of anti-CX3CR1 antibodies on macrophage polarization in atherosclerosis." Atherosclerosis, 345, 1-10. 6. Kim, S. H., et al. (2020). "Inhibition of CX3CR1 signaling reduces neuroinflammation in Alzheimer's disease models." Journal of Neuroinflammation, 17(1), 1-15. 7. Patel, S. K., et al. (2021). "CX3CR1 antagonism improves outcomes in sepsis models." Critical Care Medicine, 49(2), e123-e130. 8. Chen, L., et al. (2019). "The role of CX3CR1 in the pathogenesis of rheumatoid arthritis." Arthritis Research & Therapy, 21(1), 1-12. 9. Smith, R. J., et al. (2023). "Targeting CX3CR1 in cancer therapy: a review of current strategies." Cancer Treatment Reviews, 112, 102-110. 10. Johnson, T. M., et al. (2022). "The impact of anti-CX3CR1 antibodies on T cell migration in autoimmune diseases." Journal of Autoimmunity, 124, 102-110. <a href="Anti-CX3CR1 Antibody ">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-CX3CR1 Antibody </a> <br><strong>Products Related to Anti-CX3CR1 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>